サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：脊柱後弯症の世界市場-2023年～2030年
市場調査レポート
商品コード
1345446

脊柱後弯症の世界市場-2023年～2030年

Global Kyphoscoliosis Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 186 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
脊柱後弯症の世界市場-2023年～2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

脊柱後弯症の世界市場は、2022年に29億米ドルに達し、2023-2030年の予測期間中にCAGR 5.1%で成長し、2030年には42億米ドルに達すると予測されています。

脊柱後弯症は、冠状面（横から横へ）と矢状面（後ろから前へ）の2つの面における脊椎の異常なカーブです。後弯症と側弯症という2つの病態が組み合わさった脊椎の異常です。側弯症は、冠状面の異常な湾曲を引き起こし、背骨を水平に湾曲させます。

後弯症は、矢状面で前方または後方に不適切にねじれることにより、背中が丸くなったり、倒れたりするように見えます。一般的に3Dプリンターやコンピューター支援設計によって支援される、患者専用のインプラントや手術計画ツールの開発により、患者ごとに手術をカスタマイズすることで、手術結果を改善することができます。治療の選択肢としては、理学療法、装具、重度の場合は手術があります。これらの処置は、不快感を軽減すると同時に、姿勢や可動性を改善することを目的としています。

ダイナミクス

神経疾患の増加

神経疾患は、筋制御、協調性、および一般的な神経筋機能に影響を及ぼすため、脊柱後弯症の発症や進展に影響を及ぼしやすいです。筋ジストロフィーや脊髄性筋萎縮症などの神経疾患は、筋力低下を呈することが多いです。筋力低下は、脊柱の自然な姿勢と湾曲を維持するために必要な支持を脊柱に与えることができません。脊柱後弯症のような非典型的な脊柱の湾曲は、この筋力低下の結果として生じることがあります。

脊髄腫瘍や外傷などの一部の神経学的疾患は、脊髄を直接圧迫したり傷つけることがあります。筋肉機能と姿勢を制御する規則的な脳インパルスを妨害することで、この圧迫は、脊柱後弯症のような脊柱異常を引き起こす可能性があります。したがって、神経障害の増加は市場の成長を後押しします。

例えば、国連の最近の報告書によると、世界人口のほぼ6人に1人にあたる10億人が、アルツハイマー病やパーキンソン病、脳卒中、多発性硬化症、てんかんのような病気だけでなく、片頭痛、脳損傷、神経感染症などの神経障害に苦しんでいます。毎年、680万人がこれらの病気のために苦しんでいます。このように、神経疾患の増加は市場の急速な拡大に寄与しています。

治療における技術進歩

脊柱後弯症の診断、治療、管理はすべて、技術の進歩から大きな恩恵を受けています。このような進歩により、この疾患に対する理解が深まり、診断能力が向上し、より良い治療法が提供されるようになっています。

例えば、特に脊椎手術において一般的な医療機器は、MAGECシステムです。側弯症の進行を遅らせるため、成長期に背骨を矯正します。この治療を受ける患者の大部分は小児患者です。2020年2月13日、MAGECシステムのモデルXロッドにおいて、アクチュエータエンドキャップが装着後に剥離したとの苦情を受けて、安全性通知が発出されました。データ評価の結果、アクチュエーターエンドキャップの剥離は約0.5％の装置で起こっていたことが明らかになり、医師はすべてのシステムの移植を中止するよう促されました。

エンドキャップが分離した後、インプラントが緩んだり、腐食したり、移動したり、痛みを引き起こしたりする可能性があること、またロッドが内部装具として機能しながら伸び続けたり、逸脱したりする可能性があることに、医師は注意を促しています。その結果、アクチュエーターの内部コンポーネントが露出し、劣化が早まったり、チタン合金、摩耗粉、局所的な組織の変色がシステムに入り込む可能性があります。

治療に伴う副作用

脊柱後弯症は、症状の重篤度や患者さんの特定のニーズに応じて、装具、理学療法、手術など様々な方法で治療することができます。それぞれの治療法には、いくつかの潜在的な副作用や注意点があります。装具を長期間装着していると、皮膚の発疹、擦過傷、褥瘡が生じることがあります。

パッドと適切なフィット感によって、この問題を軽減できる可能性があります。理学療法による運動は、特に新しい運動を始めるときに筋肉痛を引き起こすことがあります。術後数週間から数ヵ月間は、手術部位の痛みや不快感を経験することがあります。痛みのコントロールは術後ケアの重要な部分です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 神経疾患の増加
      • 治療技術の進歩
    • 抑制要因
      • 治療に伴う副作用
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 タイプ別

  • 側弯症
  • 後弯症
    • 姿勢性後弯症
    • ショイエルマン後弯症
    • 加齢性後弯症
    • 先天性後弯症

第8章 疾患管理別

  • 診断
    • MRI検査
    • CTスキャン
    • 骨密度検査
    • その他
  • 薬物療法
  • 手術
    • 脊椎インプラント
    • 骨移植
    • 装具
    • その他

第9章 年齢層別

  • 児童
  • 成人

第10章 エンドユーザー別

  • 病院
  • クリニック
  • 外来手術センター

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル（1～5：診断機器メーカー、6～10：医薬品メーカー）

  • Koninklijke Philips N.V.
    • 企業概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な動向
  • Canon
  • GE Healthcare
  • Siemens
  • Hologic
  • Sri Krishna Pharmaceuticals Ltd
  • NEXGEN PHARMA INC
  • ValiantLabs.in.
  • BASF Corporation
  • Dr. Reddy's Laboratories Ltd

第14章 付録

目次
Product Code: PH6790

Overview

Global Kyphoscoliosis Market reached US$ 2.9 billion in 2022 and is expected to reach US$ 4.2 billion by 2030, growing with a CAGR of 5.1% during the forecast period 2023-2030.

Kyphoscoliosis is an abnormal curve of the spine on two planes: the coronal plane, or side to side, and the sagittal plane, or back to front. It's a combined spinal abnormality of two other conditions: kyphosis and scoliosis. Scoliosis causes an abnormal coronal plane curvature, which causes the spine to curve horizontally.

By improperly twisting forward or backward on the sagittal plane, kyphosis causes the back to seem rounded or fell. The development of patient-specific implants and surgical planning tools, typically assisted by 3D printing and computer-assisted design, can improve surgical outcomes by customising operations for each patient. Treatment options include physical therapy, bracing, and in severe situations, surgery. These procedures aim to reduce discomfort while also improving posture and mobility.

Dynamics

The Rise of Neurological Disorders

Neurological disorders can easily influence the onset and evolution of kyphoscoliosis due to their effects on muscle control, coordination, and general neuromuscular function. Neurological diseases including muscular dystrophy and spinal muscular atrophy frequently present with muscle weakness. Weak muscles are unable to provide the spine with the necessary support to maintain its natural posture and curvature. Atypical spinal curvatures, such kyphoscoliosis, may arise as a result of this weakening.

Some neurological conditions, such as spinal cord tumours or trauma, can directly compress the spinal cord or injure it. By interfering with the regular brain impulses that control muscle function and posture, this compression has the potential to result in spinal anomalies such kyphoscoliosis. Therefore, the increase of neurological disorders will boost market growth.

For instance, according to a recent United Nations report, up to 1 billion people, or nearly one in six of the world's population, suffer from neurological disorders, including migraine, brain injuries, and neuroinfections as well as diseases like Alzheimer's and Parkinson's, stroke, multiple sclerosis, and epilepsy. Each year, 6.8 million people suffer as a result of these illnesses. Thus, the rise in neurological conditions contributes to the market's rapid expansion.

Technological Advancements in the Treatment

The diagnosis, treatment, and management of kyphoscoliosis have all benefited greatly from technological improvements. These developments have increased our understanding of the disorder, improved the capacity to diagnose it, and provided better therapy options.

For instance, a common medical device, particularly in spinal surgery, is the MAGEC system. In order to slow the progression of scoliosis, the spine is braced during growth. Paediatric patients make up a large portion of the patients receiving this treatment. A safety notice was issued on February 13, 2020, in response to complaints of post-implantation separation of an actuator end cap in MAGEC system Model X rods. The data evaluation revealed that the actuator end cap separation had happened in about 0.5% of the devices, prompting doctors to stop all system implantations.

Physicians have been cautioned that after the end cap has separated, the implant may become loose, corrode, migrate, or cause pain, and that the rod may continue to extend or distract while acting as an internal brace. This could result in the actuator's internal components becoming exposed, which could speed their deterioration and allow titanium alloy, wear debris, and localised tissue discoloration to enter the system.

Side Effects Associated with the Treatment

Kyphoscoliosis can be treated in a number of ways, including bracing, physical therapy, and surgery, depending on the severity of the condition and the patient's specific needs. There are several potential side effects and considerations specific to each form of treatment. An extended period of wearing a brace may result in skin rashes, chafing, or pressure sores.

Padding and a proper fit could mitigate this issue. Physical therapy exercises may cause muscle soreness, especially when starting a new exercise routine. Patients may experience pain and discomfort at the surgical site for several weeks or months after the procedure. Pain control is a crucial part of postoperative care.

Segment Analysis

The global kyphoscoliosis market is segmented based on type, disease management, age group, end user and region.

Kyphoscoliosis can Affect Children more Easily than Adults

Kyphoscoliosis can affect children more easily than adults due to a number of issues associated to the developing spine and musculoskeletal system during childhood and adolescence. For instance, certain children have a higher risk of developing kyphoscoliosis due to congenital spine abnormalities. These anomalies might not be identified until the child's spine begins to grow and develop.

The ligaments and soft tissues that surround the spine also grow swiftly in children and teenagers. These structures may not develop properly or expand at different rates, which can cause kyphoscoliosis. Children and teenagers are more likely to participate in activities that strain the spine excessively or adopt poor postural habits. Large backpacks, protracted use of electronic gadgets while hunched over, and various badly performed tasks can strain the spine and possibly result in kyphoscoliosis. Thus, all of those factors contribute to accelerating segment expansion.

Geographical Penetration

Rising Product Approvals and Prevalence of Disease in the North American Region

A mix of historical, economic, and societal factors have contributed to the great advancement of healthcare services in North America, especially in the United States and Canada. In North America, regulatory organisations like the Food and Drug Administration (FDA) in the United States and Canada set strict guidelines for the effectiveness and safety of medications and medical devices. These organisations aid in ensuring that only secure and efficient medications are distributed.

Moreover, numerous medical research organisations, academic institutes, and healthcare facilities located in North America are at the forefront of spine-related research. To learn more about the origins, risk factors, and available treatments for kyphoscoliosis, researchers in the area are actively researching the condition. Clinical trials are required because of this area of research interest. North America is the perfect site for conducting clinical trials due to its sophisticated healthcare system and medical technologies. Clinical research can be carried out with the help of modern facilities, qualified medical personnel, and advanced imaging technology. Thus, all of these variables contribute to the region's growth.

COVID-19 Impact Analysis

Many healthcare systems had issues and delays in non-urgent care during the pandemic, including the diagnosis and treatment of kyphoscoliosis. Routine tests, imaging, and elective treatments were postponed or cancelled in a number of locations, which would have delayed the diagnosis and treatment of some patients.

Patients who rely on orthopaedic braces for their kyphoscoliosis therapy may have experienced difficulties getting their braces fitted, adjusted, or replaced when hospitals cut back on their services or during lockdowns. This could impact the effectiveness of bracing therapies. During periods of high COVID-19 activity, elective treatments, such as those to treat kyphoscoliosis, were routinely delayed to save money on medical services and reduce the risk of viral transmission in hospitals. As a result, individuals who require surgery could have to wait longer.

By Type

  • Scoliosis
  • Kyphosis
    • Postural kyphosis
    • Scheuermann's kyphosis
    • Age-related kyphosis
    • Congenital kyphosis

By Disease Management

  • Diagnosis
    • MRI
    • CT Scan
    • Bone Density Testing
    • Others
  • Medication
  • Surgery
    • Spinal Implants
    • Bone Grafts
    • Braces and Orthotics
    • Others

By Age Group

  • Children
  • Adults

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On July 05, 2022, an advanced surgery was recently performed by a skilled team of surgeons from the city's top multispecialty hospital, SIMS Hospital India, to treat a severe case of kyphoscoliosis. The spine surgery community refers to the 15-year-old Ethiopian patient, Master Tesfaye Mengesha Mersha, who has severe kyphoscoliosis, as having a "Anaconda Spine," a 110-degree deformity of the upper spine in the chest area.
  • On September 22, 2021, the first surgical procedure in the BRAIVE IDE study, which will assess the safety and efficacy of the BraiveTM growth modulation system for the treatment of progressive juvenile (JIS) or adolescent (AIS) idiopathic scoliosis, has been completed, according to Medtronic plc, the world leader in medical technology.

Competitive Landscape

The major global players in the market include Koninklijke Philips N.V., Canon, GE Healthcare, Siemens, Hologic, Sri Krishna Pharmaceuticals Ltd, NEXGEN PHARMA INC, ValiantLabs.in., BASF Corporation, Dr. Reddy's Laboratories Ltd and among others.

Why Purchase the Report?

  • To visualize the global kyphoscoliosis market segmentation based on type, disease management, age group, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of kyphoscoliosis market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global kyphoscoliosis market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Disease Management
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise of Neurological disorders
      • 4.1.1.2. Technological advancements in the Treatment
  • 4.2. Restraints
      • 4.2.1.1. Side effects associated with the treatment
    • 4.2.2. Opportunity
    • 4.2.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Scoliosis *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Kyphosis
    • 7.3.1. Postural kyphosis
    • 7.3.2. Scheuermann's kyphosis
    • 7.3.3. Age-related kyphosis
    • 7.3.4. Congenital kyphosis

8. By Disease Management

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
    • 8.1.2. Market Attractiveness Index, By Disease Management
  • 8.2. Diagnosis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 8.2.2.1. MRI
      • 8.2.2.2. CT Scan
      • 8.2.2.3. Bone Density Testing
      • 8.2.2.4. Others
  • 8.3. Medication
  • 8.4. Surgery
    • 8.4.1. Spinal Implants
    • 8.4.2. Bone Grafts
    • 8.4.3. Braces and Orthotics
    • 8.4.4. Others

9. By Age Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.1.2. Market Attractiveness Index, By Age Group
  • 9.2. Children*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Adults

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Clinics
  • 10.4. Ambulatory Surgical Centres

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
      • 11.2.6.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles (1-5 Diagnosis Device Manufacturers & 6-10 Drug Manufacturers)

  • 13.1. Koninklijke Philips N.V. *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Canon
  • 13.3. GE Healthcare
  • 13.4. Siemens
  • 13.5. Hologic
  • 13.6. Sri Krishna Pharmaceuticals Ltd
  • 13.7. NEXGEN PHARMA INC
  • 13.8. ValiantLabs.in.
  • 13.9. BASF Corporation
  • 13.10. Dr. Reddy's Laboratories Ltd

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us